18 reports

Introduction to Growth Hormone Deficiency (GHD) ##. ## What is Growth Hormone?

  • Biopharmaceutical
  • Biotechnology
  • Growth Hormone
  • World
  • Forecast
  • Growth Hormone Deficiency Treatment Algorithm
  • TREATMENT GUIDELINES FOR GROWTH HORMONE DEFICIENCY
  • Growth Hormone
  • Somatropin
  • Novo Nordisk Group
  • Pfizer Inc.
  • Versartis, Inc.

GROWTH HORMONE (GH) DEFICIENCY.

  • Growth Hormone
  • Japan
  • United States
  • Forecast
  • Market Size

Growth Hormone Deficiency (GHD) -Epidemiology Forecast to 2027 ##.

  • Growth Hormone
  • France
  • Germany
  • Italy
  • Spain

Growth Hormone Deficiency (GHD) : ##MM Market Analysis ##. ##. ##MM Market Size of Growth Hormone Deficiency (GHD) ##. ##. ##MM Percentage Share of drugs marketed for Growth Hormone Deficiency (GHD) ##. ##. ##MM Market Sales of Growth

  • Biological Therapy
  • Biopharmaceutical
  • Biotechnology
  • Growth Hormone
  • Abbreviations and Acronyms used in the report

Adult Growth Hormone Deficiency - Benefits, Side Effects, and Risks of Growth Hormone Replacement.

  • Growth Hormone
  • Pathology
  • Europe
  • Growth Hormone Deficiencies
  • 5.3 GROWTH HORMONE DEFICIENCIES BIOSIMILARS MARKET AND FORECAST
  • Growth Hormone
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited
  • GROWTH HORMONE DEFICIENCY - LATE STAGE PIPELINE, 2014
  • GROWTH HORMONE DEFICIENCY: KEY METRICS IN THE 7MM, 2014-2024
  • Growth Hormone
  • Japan
  • Novo Nordisk Group
  • Pfizer Inc.
  • Versartis, Inc.
  • GROWTH HORMONE DEFICIENCY THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2017*
  • GROWTH HORMONE DEFICIENCY THERAPEUTICS, E7 COUNTRIES, CLINICAL TRIALS BY PHASE, 2017*
  • Clinical Trial
  • Growth Hormone
  • World
  • Product Initiative
  • Pfizer Inc.
  • NUMBER OF PRODUCTS BY STAGE AND MECHANISM OF ACTION, H1 2016
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H1 2016
  • Growth Hormone
  • Obesity
  • World
  • Product Initiative
  • Helsinn Group
  • Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Dormant Products
  • Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Discontinued Products
  • Growth Hormone
  • United States
  • World
  • Product Initiative
  • Helsinn Group
  • Growth Hormone Deficiency Overview
  • Growth Hormone Deficiency - Therapeutics Assessment
  • Biopharmaceutical
  • Growth Hormone
  • Pharmaceutical
  • United States
  • Product Initiative
  • Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Clinical Trial
  • Drug Discovery And Development
  • Growth Hormone
  • World
  • Market Size
  • Deal Type

TransCon Growth Hormone is a sustained-release prodrug of recombinant human growth hormone (hGH).

  • Growth Hormone
  • Pharmaceutical
  • United States
  • Company
  • GlobalData's company
  • Official Title

Interaction of Testosterone and Growth Hormone at the Hepatic Level GDCT## ACTRN##, Hormonal Disorders Hypopituitarism, Male Hypogonadism Completed Phase IV Interventional somatropin; testosterone; testosterone ER St.

  • Growth Hormone
  • Healthcare
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.
  • Clinical Trial profile. 2 Trial Title
  • Official Title
  • Biopharmaceutical
  • Growth Hormone
  • Therapy
  • World
  • Product Initiative
  • Nov 16, 2016: Genexine Granted FDA Orphan Drug Designation for GX-H9 in Growth Hormone Deficiency
  • Sep 13, 2016: Genexine Announces Phase 2 Clinical Data of GX-H9 in ePoster presentation at ESPE 2016
  • Growth Hormone
  • Pharmaceutical
  • China
  • South Korea
  • Genexine Co., Ltd.
  • BBT-031
  • Bolder Biotechnology, Inc., Key Facts
  • Growth Hormone
  • R&D
  • Research And Development
  • United States
  • Bolder BioTechnology, Inc.